10Y UST5.31%+0.57%30Y MTG7.28%+3.56%SOFR3.90%+0.26%VNQ$89.07-0.96%XLRE$40.74-0.86%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
PR Newswire · Boston · Office

CHEMISTRY ACQUIRES COLOSSUS, ESTABLISHING A BOSTON OFFICE AND EXPANDING CREATIVE AND DESIGN CAPABILITIES

Via PR Newswire · October 7, 2026
Compiled by Real Estate Trail Editorial · October 7, 2026

Why this matters

Office continues to trade in two distinct markets: trophy assets in walkable submarkets that are leasing at or near record rents, and commodity Class B and C buildings where the basis is still resetting. Underwriting on the latter has moved toward replacement-cost-minus, with credit underwriting now leaning on tenant covenant and remaining lease term rather than mark-to-market expectations. Boston life sciences absorption has moderated from its 2021-2022 pace, and the market is working through a meaningful Cambridge sublease overhang. Multifamily and trophy office remain durable. For LP-positioned capital, the read-through is that the bifurcation is now a structural feature of the sector, not a cycle to wait out.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

Computed from Real Estate Trail’s own tracked coverage

Excerpt from PR Newswire:
Acquisition brings one of the industry's most recognized independent creative shops into Chemistry and marks the opening of its fifth U.S. office PITTSBURGH and BOSTON, Oct. 7, 2026 /PRNewswire/ -- Independent agency…
Read the full article at PR Newswire →

External link. Real Estate Trail does not republish source content.

Related coverage — Boston · Office

Connect CRE · Boston · Office

Monarch Capital Makes First Acquisition with Off-Market Deal

Monarch Capital Partners, a Boston-based commercial real estate investment firm, completed its first acquisition: 115 & 117 Flanders Rd. in Westborough, MA. The 115,241-square-foot flex/R&D/office and shallow-bay indu…

Oct 5